Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Lang

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Hematology & Oncology|March 19, 2021
Third-line therapy for chronic myeloid leukemia: current status and future directionsJorge Cortes, Fabian Lang
Blood|February 6, 2025
Asciminib for Ph+ ALL: a step forward?Fabian Lang, Oliver G Ottmann
Oncotarget|January 10, 2018
On the hunt for B-cell lymphoblastic leukemia-initiating stem cellsBartosch Wojcik, Fabian Lang, Michael A Rieger
Organic & Biomolecular Chemistry|March 21, 2023
Aminophthalimide as a mimetic of purines and a fluorescent RNA base surrogate for RNA imagingFabian Lang, Franziska Rönicke, Hans-Achim Wagenknecht
Stem Cells International|August 4, 2015
Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaFabian Lang, Bartosch Wojcik, Michael A Rieger
Organic & Biomolecular Chemistry|May 21, 2024
Cell-resistant wavelength-shifting molecular beacons made of L-DNA and a clickable L-configured uridineFabian Lang, Franziska Rönicke, Hans-Achim Wagenknecht
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 18, 2026
Dihydroquinazolinones by Titanocene-Catalyzed Reductive Radical Addition to QuinazolinonesThomas Heinrichs, Fabian Lang, Konstantin Woitol, et al.
Oncology Research and Treatment|May 16, 2024
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intensity Chemotherapy, to Compare End of Therapy with Indication for Stem Cell Transplantation versus Tyrosine Kinase Inhibitor, Blinatumomab, and Chemotherapy in Optimal Responders, and to Evaluate Blinatumomab in Suboptimal Responders (GMALL-EVOLVE)Fabian Lang, Heike Pfeifer, Monika Brüggemann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 7, 2023
Enantio- and Diastereomerically Pure Titanocenes by Dynamic Conformational LockingTobias Hilche, Tim Krebs, Hendrik Weißbarth, et al.
The American Journal of Case Reports|October 17, 2017
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment OptionsFabian Lang, Lydia Wunderle, Heike Pfeifer, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Hematology & Oncology|March 19, 2021
Third-line therapy for chronic myeloid leukemia: current status and future directionsJorge Cortes, Fabian Lang
Blood|February 6, 2025
Asciminib for Ph+ ALL: a step forward?Fabian Lang, Oliver G Ottmann
Oncotarget|January 10, 2018
On the hunt for B-cell lymphoblastic leukemia-initiating stem cellsBartosch Wojcik, Fabian Lang, Michael A Rieger
Organic & Biomolecular Chemistry|March 21, 2023
Aminophthalimide as a mimetic of purines and a fluorescent RNA base surrogate for RNA imagingFabian Lang, Franziska Rönicke, Hans-Achim Wagenknecht
Stem Cells International|August 4, 2015
Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaFabian Lang, Bartosch Wojcik, Michael A Rieger
Organic & Biomolecular Chemistry|May 21, 2024
Cell-resistant wavelength-shifting molecular beacons made of L-DNA and a clickable L-configured uridineFabian Lang, Franziska Rönicke, Hans-Achim Wagenknecht
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 18, 2026
Dihydroquinazolinones by Titanocene-Catalyzed Reductive Radical Addition to QuinazolinonesThomas Heinrichs, Fabian Lang, Konstantin Woitol, et al.
Oncology Research and Treatment|May 16, 2024
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intensity Chemotherapy, to Compare End of Therapy with Indication for Stem Cell Transplantation versus Tyrosine Kinase Inhibitor, Blinatumomab, and Chemotherapy in Optimal Responders, and to Evaluate Blinatumomab in Suboptimal Responders (GMALL-EVOLVE)Fabian Lang, Heike Pfeifer, Monika Brüggemann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 7, 2023
Enantio- and Diastereomerically Pure Titanocenes by Dynamic Conformational LockingTobias Hilche, Tim Krebs, Hendrik Weißbarth, et al.
The American Journal of Case Reports|October 17, 2017
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment OptionsFabian Lang, Lydia Wunderle, Heike Pfeifer, et al.
Pageof 5